MedPath

Effect of Sodium Rinsing Fluid on Blood Pressure and Interdialytic Weight Change in Hemodialysis Patients

Phase 4
Conditions
Hemodialysis
End-Stage Kidney Disease
Interventions
Drug: Dextrose 5%
Drug: normal saline
Registration Number
NCT02590081
Lead Sponsor
Penang Hospital, Malaysia
Brief Summary

This is a prospective, randomized, double-blind, parallel group trial to assess the efficacy and safety of intravenous dextrose 5% solution compare with normal saline (standard care) in wash back procedure during haemodialysis in patients with end stage renal failure (ESRF) with respect to systolic blood pressure control over 3 months period.

The primary objective is to establish efficacy of 5% dextrose solution compared with normal saline (0.9% sodium chloride solution) with respect to systolic blood pressure control in subjects with end stage renal failure (ESRF) on regular hemodialysis. Secondary objectives include monitoring the change in body weight, thirst level and body fluid volume.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
434
Inclusion Criteria
  • Ambulatory, clinically stable maintenance HD patients on a thrice weekly HD regime.
  • Have regular hemodialysisforat least 6 months or more.
  • Willing and able to provide written, signed informed consent after the nature of the study has been explained.
  • Willing and able to comply with all study procedures.
  • Age ≥18 years; Age < 75 years old
Exclusion Criteria
  • Diabetes mellitus, Malignancy, Pregnancy
  • Inability or unwillingness to provide written consent.
  • Inability or unwillingness to comply with the requirements of the protocol as determined by the investigator.
  • Simultaneous participation in another clinical study except observational trials
  • Any psychological condition which could interfere with the patient's ability to comply with the study protocol
  • Inability to perform a blood pressure measurement on the upper limb
  • Scheduled for living donor kidney transplant, change to peritoneal dialysis, home HD or plans to relocate to another center during the study period.
  • Life expectancy < 6 months
  • Recent acute myocardial infarction, congestive cardiac failure, stroke, angina or ICU admission within last 6 months,
  • Planned to migrate/move out of the city
  • Alcohol abuse/ drug abuse within last 6 months
  • Missed > 2 hemodialysis sessions over 1 month
  • Requiring non- cuff catheter for hemodialysis
  • Admitted for major infection within the last one month

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
dextrose 5%Dextrose 5%Dextrose 5% will be used for wash back procedure at the end of hemodiaysis.
Normal salinenormal salineNormal saline will be used for wash back procedure at the end of hemodiaysis.
Primary Outcome Measures
NameTimeMethod
systolic blood pressure controlTime from week 0 until week 12

post intervention systolic blood pressure reduction compared to baseline

Secondary Outcome Measures
NameTimeMethod
Interdialytic weight gainTime from week 0 until week 12

reduced Interdialytic weight gain in experimental group

thirst levelTime from week 0 and week 12

Dialysis thirst inventory questionnaire to be administer by patient at baseline (week 0) and end of trial (week 12)

intradialytic eventTime from week 0 until week 12

Any incident occuring during hemodialysis treatment which needed medical intervention. The event are chills and rigor, chest pain, giddiness, cramps, vomiting, blood loss and hypotension.

adverse eventsTime from week 0 until week 12

All observed or spontaneously reported adverse events occur during the trial period.

Trial Locations

Locations (15)

Seberang Jaya Hospital

🇲🇾

Seberang Jaya, Penang, Malaysia

Hospital Sungai Bakap

🇲🇾

Sungai Bakap, Penang, Malaysia

Miri Hospital

🇲🇾

Miri, Sarawak, Malaysia

UKM Medical Centre

🇲🇾

Cheras, Wilayah persekutuan Kuala lumpur, Malaysia

Hospital Kuala Lumpur

🇲🇾

Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur, Malaysia

Hospital Kepala Batas

🇲🇾

Kepala Batas, Penang, Malaysia

Selayang Hospital

🇲🇾

Selayang, Selangor, Malaysia

Hospital Sultanah Bahiyah, Alor Setar

🇲🇾

Alor Setar, Kedah, Malaysia

Hospital Bukit Mertajam

🇲🇾

Bukit Mertajam, Penang, Malaysia

Hospital Balik Pulau

🇲🇾

Balik Pulau, Penang, Malaysia

UM Medical Centre

🇲🇾

Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur, Malaysia

Hospital Tengku Ampuan Afzan

🇲🇾

Kuantan, Pahang, Malaysia

Penang Hospital

🇲🇾

George Town, Penang, Malaysia

Hospital Serdang

🇲🇾

Serdang, Selangor, Malaysia

Hospital Tuanku Jaafar

🇲🇾

Seremban, Negeri Sembilan, Malaysia

© Copyright 2025. All Rights Reserved by MedPath